Medulloblastoma with myogenic differentiation: Long-term survival in a patient treated with aggressive combination therapy and autologous stem cell transplantation

William Rattenberry, Colleen H. McDonough, Peter C. Burger, Kenneth J. Cohen

Research output: Contribution to journalArticle


Medulloblastoma with myogenic differentiation (MMD) is a rare and aggressive variant of medulloblastoma, occurring predominantly in children. There have been only two case reports of long-term survival previously published. We report a case of long-term disease-free survival in a 21-year-old diagnosed with MMD.

Original languageEnglish (US)
Pages (from-to)659-662
Number of pages4
JournalJournal of neuro-oncology
Issue number3
StatePublished - Dec 1 2011



  • Autologous stem cell rescue
  • Medulloblastoma with myogenic differentiation
  • Medullomyoblastoma

ASJC Scopus subject areas

  • Oncology
  • Neurology
  • Clinical Neurology
  • Cancer Research

Cite this